Jeffrey Tate - Net Worth and Insider Trading

Jeffrey Tate Net Worth

The estimated net worth of Jeffrey Tate is at least $93,773 dollars as of 2024-05-04. Jeffrey Tate is the COO of Cyclo Therapeutics Inc and owns about 62,101 shares of Cyclo Therapeutics Inc (CYTH) stock worth over $93,773. Details can be seen in Jeffrey Tate's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jeffrey Tate has not made any transactions after 2023-04-20 and currently still holds the listed stock(s).

Transaction Summary of Jeffrey Tate

To

Jeffrey Tate Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeffrey Tate owns 1 companies in total, including Cyclo Therapeutics Inc (CYTH) .

Click here to see the complete history of Jeffrey Tate’s form 4 insider trades.

Insider Ownership Summary of Jeffrey Tate

Ticker Comapny Transaction Date Type of Owner
CYTH Cyclo Therapeutics Inc 2023-04-20 director & Chief Executive Officer

Jeffrey Tate Latest Holdings Summary

Jeffrey Tate currently owns a total of 1 stock. Jeffrey Tate owns 62,101 shares of Cyclo Therapeutics Inc (CYTH) as of April 20, 2023, with a value of $93,773.

Latest Holdings of Jeffrey Tate

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CYTH Cyclo Therapeutics Inc 2023-04-20 62,101 1.51 93,773

Holding Weightings of Jeffrey Tate


Jeffrey Tate Form 4 Trading Tracker

According to the SEC Form 4 filings, Jeffrey Tate has made a total of 4 transactions in Cyclo Therapeutics Inc (CYTH) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Cyclo Therapeutics Inc is the acquisition of 29,941 shares on April 20, 2023, which cost Jeffrey Tate around $21,258.

Insider Trading History of Jeffrey Tate

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jeffrey Tate Trading Performance

GuruFocus tracks the stock performance after each of Jeffrey Tate's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey Tate is 34.03%. GuruFocus also compares Jeffrey Tate's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey Tate within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jeffrey Tate's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jeffrey Tate

Average Return

Average return per transaction

Outperforming Transactions

1 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 15.09
Relative Return to S&P 500(%) 15.17

Jeffrey Tate Ownership Network

Ownership Network List of Jeffrey Tate

No Data

Ownership Network Relation of Jeffrey Tate


Jeffrey Tate Owned Company Details

What does Cyclo Therapeutics Inc do?

Who are the key executives at Cyclo Therapeutics Inc?

Jeffrey Tate is the director & Chief Executive Officer of Cyclo Therapeutics Inc. Other key executives at Cyclo Therapeutics Inc include 10 percent owner Rafael Holdings, Inc. , SVP for Medical Affairs Sharon Hemond Hrynkow , and Chief Medical Officer Lise Lund Kjems .

Cyclo Therapeutics Inc (CYTH) Insider Trades Summary

Over the past 18 months, Jeffrey Tate made 1 insider transaction in Cyclo Therapeutics Inc (CYTH) with a net purchase of 29,941. Other recent insider transactions involving Cyclo Therapeutics Inc (CYTH) include a net purchase of 4,000,000 shares made by Rafael Holdings, Inc. , a net purchase of 299,402 shares made by N Scott Fine , and a net purchase of 59,881 shares made by Francis Patrick Ostronic .

In summary, during the past 3 months, insiders sold 0 shares of Cyclo Therapeutics Inc (CYTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclo Therapeutics Inc (CYTH) were sold and 4,449,105 shares were bought by its insiders, resulting in a net purchase of 4,449,105 shares.

Cyclo Therapeutics Inc (CYTH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cyclo Therapeutics Inc Insider Transactions

No Available Data

Jeffrey Tate Mailing Address

Above is the net worth, insider trading, and ownership report for Jeffrey Tate. You might contact Jeffrey Tate via mailing address: C/o Ctd Holdings, Inc., 27317 Nw 78th Avenue, High Springs Fl 32643.

Discussions on Jeffrey Tate

No discussions yet.